F/M Investments’s Repligen RGEN Stock Holding History

F/M Investments’s Portfolio RGEN Stock Details RGEN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q2	–	Sell	-10,482	Closed	-$2.04M	–	90
2021 Q1	$2.04M	Buy	10,482 +9,366	+839%	+$1.92M	1.61%	23
2020 Q4	$214K	Buy	+1,116	New	+$203K	0.19%	55

Other funds holding RGEN

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

FAM

Fred Alger Management New York $22.8B AUM 64.63% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Select Equity Group New York $19.5B AUM 17.33% 1-Year Est. Return

AllianceBernstein Nashville, Tennessee $309B AUM 23.92% 1-Year Est. Return

1WCM

12 West Capital Management New York $592M AUM 40.75% 1-Year Est. Return

CCA

Conestoga Capital Advisors Wayne, Pennsylvania $5.01B AUM 6.26% 1-Year Est. Return

F/M Investments's RGEN Position: Q2 2021 in Review

F/M Investments sold out of Repligen (RGEN) in Q2 2021, closing a stake of 10,482 shares — an estimated $2.04M sold.

F/M Investments first reported a position in RGEN in Q4 2020 and held it in 2 quarters. The position peaked at $2.04M in Q1 2021. 428 funds tracked by Wall St. Rank hold RGEN as of Q2 2021.

F/M Investments reported no remaining Repligen position as of Q2 2021 after selling out during the quarter.
F/M Investments sold 10,482 Repligen shares in Q2 2021, an estimated $2.04M.
F/M Investments first reported a position in Repligen in Q4 2020 and held it in 2 quarters.
F/M Investments's Repligen position peaked at $2.04M in Q1 2021.
428 funds tracked by Wall St. Rank held Repligen as of Q2 2021.

Based on F/M Investments's 13F filing for Q2 2021, filed 10 Aug 2021.